Shares of Boston Scientific Corporation (BSX) Drops by -1.34%

Boston Scientific Corporation (BSX) has risen sharply, recording gains of 4.85% in the past 4 weeks. However, the stock has corrected -1.34% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 0.46% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week. The stock has recorded a 20-day Moving Average of 1.99% and the 50-Day Moving Average is 3.65%.

Boston Scientific Corporation (NYSE:BSX): The stock opened at $23.89 on Friday but the bulls could not build on the opening and the stock topped out at $23.94 for the day. The stock traded down to $23.52 during the day, due to lack of any buying support eventually closed down at $23.58 with a loss of -0.84% for the day. The stock had closed at $23.78 on the previous day. The total traded volume was 6,094,254 shares.


The company Insiders own 1.31% of Boston Scientific Corporation shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -21.25% . Institutional Investors own 93.28% of Boston Scientific Corporation shares. During last six month period, the net percent change held by insiders has seen a change of -25.56%. In a related news,The officer (EVP, GC & Chief Admin Officer) of Boston Scientific Corp, Pratt Timothy A. sold 24,000 shares at $23.39 on July 1, 2016. The Insider selling transaction had a total value worth of $561,360. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.

Boston Scientific Corporation develops, manufactures and markets medical devices. The Company offers its products by seven core businesses: Interventional Cardiology, which includes Drug-Eluting Coronary Stent Systems, Intravascular Imaging devised and Coronary Technology products, such as guide wires, guide catheters, and balloon catheters, among others; Peripheral Interventions (PI), which include stents, balloon catheters, wires, peripheral embolization devices and vena cava filters; Cardiac Rhythm Management (CRM), which include implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities; Electrophysiology (EP), which include steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories; Endoscopy, which includes Spyglass System, WallFlex Colonic Stents, Resolution Clip, and Expect Aspiration Needle, among others; Urology and Womens Health, and Neuromodulation.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.